Related Experiment Video

Updated: Jul 1, 2025

Isolation of Brain-infiltrating Leukocytes
06:44

Isolation of Brain-infiltrating Leukocytes

Published on: June 13, 2011

19.2K

Tick-borne illnesses in patients treated with B-cell depleting agents: Considerations for neurologists

Hamza Coban1

  • 1Department of Neurology, University of Connecticut School of Medicine, University of Connecticut Health Center, Farmington, CT, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|March 7, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

Related Experiment Videos

Last Updated: Jul 1, 2025

Isolation of Brain-infiltrating Leukocytes
06:44

Isolation of Brain-infiltrating Leukocytes

Published on: June 13, 2011

19.2K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

47.3K
Overview
47.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179

Articles linked to this work by shared authors, journal, and citation graph.

Total Tau Level in Cerebrospinal Fluid as a Predictor of Survival in Creutzfeldt-Jakob Disease: A Retrospective Analysis.

Neurology. Clinical practice·2023

A group resilience training program for people with multiple sclerosis: A cluster-randomized controlled trial (multi-READY for MS).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Cesarean sections prior to 39 weeks among pregnant patients with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Racial disparities in multiple sclerosis quality of care metrics.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Ultra-processed foods and multiple sclerosis: Evidence, pitfalls and perspectives.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Global prevalence of multiple sclerosis surpasses 3 million: 2024 update of the Multiple Sclerosis International Federation Atlas of MS.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Impact of multiple sclerosis symptoms survey: Patient-reported data on the prevalence, burden, and management of multiple sclerosis symptoms in Europe.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

The spatial architecture of tumor immunity: Emerging predictive biomarkers across cancer.

Immunologic research·2026

Inflammatory Soft Tissue Tumors: A Wolf in Sheep's Clothing.

Archives of pathology & laboratory medicine·2026

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

Leukemia & lymphoma·2026

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer.

Scientific reports·2026

Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy.

PloS one·2026

Spatial statistics infer structured immune signatures in primary prostate cancer.

Cancer immunology research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us